Polyaniline nano-material applied to pharmaceutical analysis and preparation method of polyaniline nano-material
By using a combination of carboxymethyl chitosan and surfactant in the preparation of polyaniline nanomaterials, the soluble and stable problems of polyaniline nanomaterials in the fields of drug analysis and disease diagnosis were solved, and a large specific surface area and good quality were prepared. Dispersible nanomaterials realize the application prospects in the fields of drug analysis and disease diagnosis.
Patent Information
- Application Number
- CN202411006904.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-25
- Publication Date
- 2024-11-12
AI Technical Summary
The existing polyaniline nanomaterials are limited by the shortcomings of extremely poor solubleness, small specific surface area, irregular morphology, poor dispersion, and poor stability in the fields of drug analysis and disease diagnosis.
Using the combination of carboxymethyl chitosan, bisamide sulfobetaine, imidazoline quaternary ammonium surfactant, etc., in situ polymerization is initiated by microwave drying and ammonium persulfate and benzoyl peroxide oxidizing agent to prepare large Polyaniline nanomaterial with good specific surface area, regular morphology and dispersion.
The obtained polyaniline nanomaterial has good solubleness, charge transport capability and biocompatibility, is suitable for drug analysis and disease diagnosis, and has excellent sensor material properties.
Smart Images

Figure CN118931180A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of nano materials, in particular to a polyaniline nano material used for drug analysis and a preparation method thereof. Background Art
[0002] Polyaniline (PANI) is one of the most promising conductive polymers due to its simple synthesis process, good environmental stability, and excellent electrochemical performance. However, due to its strong hydrophobicity and poor dispersibility in water, polyaniline has extremely poor solubility and is almost insoluble in most commonly used organic solvents. It is only partially soluble in N,N-dimethylformamide and N-methylpyrrolidone, which greatly limits the application of polyaniline.
[0003] Polyaniline nanomaterials are increasingly playing a role in the fields of light, electricity, sound and magnetism due to their unique structure, strong oxidation / protonation, efficient intrinsic charge transfer ability and low contact resistance between particles. However, the nano-polyaniline obtained so far has the disadvantages of extremely poor solubility, small specific surface area, irregular morphology, poor dispersibility and poor stability. Therefore, the application of polyaniline nanomaterials in the fields of drug analysis and disease diagnosis is subject to certain restrictions.
[0004] The disclosure of the above background technology content is only used to assist in understanding the inventive concept and technical solution of the present invention. It does not necessarily belong to the prior art of this patent application. In the absence of clear evidence that the above content has been disclosed on the filing date of this patent application, the above background technology should not be used to evaluate the novelty and creativity of the present application. Summary of the invention
[0005] The present invention aims at solving the above problems and provides a polyaniline nanomaterial for drug analysis and a preparation method thereof. The polyaniline nanomaterial prepared by the present invention has the advantages of large specific surface area, regular morphology, good dispersibility, good solubility, strong charge transfer ability, good biocompatibility, etc., and has good application prospects in the fields of drug analysis, disease diagnosis, etc.
[0006] In order to achieve the above purpose, the technical solution adopted by the present invention is as follows:
[0007] A method for preparing a polyaniline nanomaterial for drug analysis comprises the following steps:
[0008] (1) dissolving carboxymethyl chitosan in isopropanol, adding bisamide sulfobetaine and imidazoline quaternary ammonium salt surfactant, stirring at room temperature for 1-3 hours, and drying by microwave at a temperature of 50-60° C.;
[0009] (2) dissolving the chitosan derivative in water to prepare a 30-50 g / L solution, adding aniline monomer and dispersant, stirring at 25-35° C. for 12-24 hours; then adding ammonium persulfate and benzoyl peroxide oxidant, stirring at 20-25° C. for 6-12 hours to obtain a polyaniline product;
[0010] (3) The polyaniline product is subjected to high-speed centrifugation, and the precipitate is dried to obtain the polyaniline nanomaterial.
[0011] Further, the dispersant includes one or more combinations of polyoxyethylene stearate, polyethylene glycol 200, glycidyl neodecanoate, and polyacrylamide. Preferably, the dispersant is added in an amount of 3-5 g per liter of solution.
[0012] Furthermore, the ratio of the carboxymethyl chitosan to isopropanol is 1-5 g / 100 mL.
[0013] Furthermore, the mass ratio of the chitosan derivative to the aniline monomer is 1-5:1.
[0014] Further, the molar ratio of the oxidant to the aniline monomer is 1-1.5: 1. Preferably, the molar ratio of ammonium persulfate to benzoyl peroxide in the oxidant is 1-3:1.
[0015] Furthermore, the mass ratio of the compound surfactant to carboxymethyl chitosan is 3-5:100.
[0016] Furthermore, the high-speed centrifugation is performed at a rotation speed of 10000-20000 r / min for 10-30 min.
[0017] Furthermore, the drying in step (3) is microwave drying at a temperature of 60-80°C.
[0018] Compared with the prior art, the advantages and beneficial effects of the present invention are:
[0019] The invention provides chitosan with a bisamide type sulfobetaine and an imidazoline quaternary ammonium salt surfactant, thereby giving the chitosan excellent water solubility and cationic groups, and then mixing the porous chitosan with an aniline monomer and a dispersant in a water system, and then in-situ polymerization is initiated by ammonium persulfate and benzoyl peroxide oxidants to prepare a polyaniline nano material. The prepared aniline nano material has the advantages of large specific surface area, regular morphology, good dispersibility, good solubility, strong charge transfer ability, good biocompatibility, etc., and can be used as an excellent sensor material, and has good application prospects in the fields of drug analysis, disease diagnosis, etc. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] Figure 1This is a transmission electron microscope image of the polyaniline nanomaterial prepared in Example 1 of the present invention. DETAILED DESCRIPTION
[0021] The present invention will be further described in detail below in conjunction with specific embodiments. It should be emphasized that the following description is merely exemplary and is not intended to limit the scope of the present invention and its application.
[0022] Example 1
[0023] A method for preparing a polyaniline nanomaterial for drug analysis comprises the following steps:
[0024] (1) Dissolve 100 g of carboxymethyl chitosan in 5 L of isopropanol, add 1 g of bisamide sulfobetaine and 4 g of imidazoline quaternary ammonium salt surfactant, stir at room temperature for 2 h, and microwave dry at 60 °C;
[0025] (2) dissolving the chitosan derivative in water to prepare a 40 g / L solution, adding 50 g of aniline monomer and polyoxyethylene stearate dispersant (3 g per liter of solution), stirring at 30° C. for 24 h; then adding ammonium persulfate and benzoyl peroxide oxidant in a molar ratio of 2:1, wherein the molar ratio of the oxidant to the aniline monomer is 1:1, stirring at a temperature of 22° C. for 10 hours to obtain a polyaniline product;
[0026] (3) The polyaniline product is centrifuged at a rotation speed of 10000 r / min for 25 min and then microwave dried at a temperature of 70° C. to obtain a polyaniline nanomaterial.
[0027] 1 g of the polyaniline nanomaterial prepared in this example was dissolved in 1 L of water and observed under a transmission electron microscope. The results are as follows: Figure 1 As shown in the figure, it can be seen that the polyaniline nanomaterial is easily soluble in water and has good dispersibility. The particle size of the material was tested using a laser particle size analyzer, and the particle size distribution was measured to be between 40-50nm.
[0028] The polyaniline nanomaterial prepared in this example is used as a sensing material, and its response sensitivity to ascorbic acid is 417 μA·mM -1 cm -2, The detection limit is 1.0 ng / mL, which indicates that the sensor can be used for the determination and analysis of drug content and has good application prospects in drug analysis.
[0029] Example 2
[0030] A method for preparing a polyaniline nanomaterial for drug analysis comprises the following steps:
[0031] (1) 250 g of carboxymethyl chitosan was dissolved in 5 L of isopropanol, and then 4 g of bisamide sulfobetaine and 4 g of imidazoline quaternary ammonium salt surfactant were added, stirred at room temperature for 3 h, and microwave dried at 50 °C;
[0032] (2) dissolving the chitosan derivative in water to prepare a 50 g / L solution, adding 100 g of aniline monomer and neodecanoic acid glycidyl ester dispersant (5 g per liter of solution), stirring at 25° C. for 24 h; then adding ammonium persulfate and benzoyl peroxide oxidant in a molar ratio of 1:1, wherein the molar ratio of the oxidant to the aniline monomer is 1.2:1, stirring at a temperature of 22° C. for 10 hours to obtain a polyaniline product;
[0033] (3) The polyaniline product is centrifuged at a rotation speed of 15000 r / min for 10 min and then microwave dried at a temperature of 60° C. to obtain polyaniline nanomaterials.
[0034] The particle size of the polyaniline nanomaterial was tested using a laser particle size analyzer, and the particle size distribution was measured to be between 50-70nm.
[0035] The polyaniline nanomaterial prepared in this example is used as a sensing material, and the response sensitivity to ascorbic acid is 373 μA·mM -1 cm -2 The detection limit is 2.5ng / mL. This shows that the sensor can be used for the determination and analysis of drug content and has good application prospects in drug analysis.
[0036] Example 3
[0037] A method for preparing a polyaniline nanomaterial for drug analysis comprises the following steps:
[0038] (1) Dissolve 200 g of carboxymethyl chitosan in 5 L of isopropanol, add 6 g of bisamide sulfobetaine and 4 g of imidazoline quaternary ammonium salt surfactant, stir at room temperature for 1.5 h, and microwave dry at 60 °C;
[0039] (2) dissolving the chitosan derivative in water to prepare a 50 g / L solution, adding 200 g of aniline monomer and neodecanoic acid glycidyl ester dispersant (3 g per liter of solution), stirring at 35° C. for 18 h; then adding ammonium persulfate and benzoyl peroxide oxidant in a molar ratio of 2:1, wherein the molar ratio of the oxidant to the aniline monomer is 1.5:1, stirring at a temperature of 20° C. for 8 hours to obtain a polyaniline product;
[0040] (3) The polyaniline product is centrifuged at a rotation speed of 20000 r / min for 20 min and then microwave dried at a temperature of 80° C. to obtain polyaniline nanomaterials.
[0041] The particle size of polyaniline nanomaterials was tested by a laser particle size analyzer, and the particle size distribution was measured to be between 40-55nm.
[0042] The polyaniline nanomaterial prepared in this example is used as a sensing material, and the response sensitivity to ascorbic acid is 402 μA·mM -1 cm -2 The detection limit is 1.5ng / mL. This shows that the sensor can be used for the determination and analysis of drug content and has good application prospects in drug analysis.
[0043] 1 g of the polyaniline nanomaterial prepared in Example 1-3 was dissolved in 1 L of water, and the absorbance change was tracked by a UV-visible spectrophotometer. The test results are shown in Table 1.
[0044] Table 1: Test results of relative absorbance variation of polyaniline nanomaterials prepared by the present invention over time
[0045]
[0046] From the above test results, it can be seen that the relative absorbance of the polyaniline nanomaterial prepared by the present invention is still above 90% after 72 hours, which shows that the material prepared by this scheme has good dispersibility.
[0047] The above contents are further detailed descriptions of the present invention in combination with specific / preferred embodiments.
[0048] It cannot be considered that the specific implementation of the present invention is limited to these descriptions. For ordinary technicians in the technical field to which the present invention belongs, they can also make several substitutions or modifications to these described embodiments without departing from the concept of the present invention, and these substitutions or modifications should be considered to fall within the scope of protection of the present invention.
Claims
1. A method for preparing polyaniline nanomaterials for drug analysis, characterized in that: The steps include: (1) dissolving carboxymethyl chitosan in isopropanol, adding a bisamide type sulfobetaine and an imidazoline quaternary ammonium salt composite surfactant, stirring at room temperature for 1-3 hours, and drying by microwave at a temperature of 50-60° C. to obtain a chitosan derivative; (2) dissolving the chitosan derivative in water to prepare a 30-50 g / L solution, adding aniline monomer and dispersant, stirring at 25-35° C. for 12-24 hours; then adding ammonium persulfate and benzoyl peroxide oxidant, stirring at 20-25° C. for 6-12 hours to obtain a polyaniline product; (3) The polyaniline product is subjected to high-speed centrifugation, and the precipitate is dried to obtain the polyaniline nanomaterial.
2. The method for preparing polyaniline nanomaterials for drug analysis according to claim 1, characterized in that: The dispersant includes one or more combinations of polyoxyethylene stearate, polyethylene glycol 200, glycidyl neodecanoate, and polyacrylamide; the amount of the dispersant added is 3-5 g per liter of solution.
3. The method for preparing polyaniline nanomaterials for drug analysis according to claim 1, characterized in that: The ratio of the carboxymethyl chitosan to isopropanol is 1-5 g / 100 mL.
4. The method for preparing polyaniline nanomaterials for drug analysis according to claim 1, characterized in that: The mass ratio of the chitosan derivative to the aniline monomer is 1-5:
1.
5. The method for preparing polyaniline nanomaterials for drug analysis according to claim 1, characterized in that: The molar ratio of the oxidant to the aniline monomer is 1-1.5:
1.
6. The method for preparing polyaniline nanomaterials for drug analysis according to claim 5, characterized in that: The molar ratio of ammonium persulfate to benzoyl peroxide in the oxidant is 1-3:
1.
7. The method for preparing polyaniline nanomaterials for drug analysis according to claim 2, characterized in that: The mass ratio of the composite surfactant to carboxymethyl chitosan is 3-5:
100.
8. The method for preparing polyaniline nanomaterials for drug analysis according to claim 1, characterized in that: The high-speed centrifugation is performed at a rotation speed of 10000-20000 r / min for 10-30 min.
9. The method for preparing polyaniline nanomaterials for drug analysis according to claim 1, characterized in that: The drying in step (3) is carried out by microwave drying at a temperature of 60-80°C.
10. The use of the polyaniline nanomaterial as claimed in claim 1, wherein the polyaniline nanomaterial is used as a sensor material in drug analysis.
